Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199227-12-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Financial Results & Limited Review for Sept 30, 2013
Neuland Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013.Neuland Labs' Track Record of cGMP Excellence complemented by 2013 CMO Leadership Award for Regulatory Excellence
Neuland Laboratories Ltd has informed BSE regarding a Press Release dated October 16, 2013, titled "Neuland Labs' Track Record of cGMP Excellence complemented by 2013 CMO Leadership Award for Regulatory Excellence".Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Updates on Outcome of AGM
Neuland Laboratories Ltd has submitted to BSE a copy of the Minutes of the 29th Annual General Meeting (AGM) of the Company held on August 02, 2013.Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Neuland Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992Results Press Release
Neuland Laboratories Ltd has submitted to BSE a copy of Results Press Release for the period ended June 30, 2013.Outcome of AGM
Neuland Laboratories Ltd has informed BSE that the 29th Annual General Meeting (AGM) of the Company was held on August 02, 2013.Financial Results & Limited Review for June 30, 2013
Neuland Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013.Clarification
With reference to Increase in Price, Neuland Laboratories Ltd has clarified to BSE that there is no such information withheld by the Company, which is price sensitive in nature and required to be disclosed to the Stock Exchanges as on date.